Aglaris
PrivateLast Round
Grant
Apr 1, 2019
Total Funding Raised
$1.67M
Company Overview
Aglaris is a biotechnology company that develops and manufactures fully automated, closed-system bioreactors for cell and gene therapy production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aglaris Comparables
Compare Aglaris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scinus Cell Expansion | 91% | |
| Limula | 89% | |
| MFX | 87% |
Aglaris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2019 | ||||
| Grant | Jun 1, 2016 | ||||
| VC Round | Mar 1, 2016 |
Key People
Founding team and executive leadership
Aglaris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| CRB Bio II | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Grew 36% QoQ, from 11 to 15 employees.
- Apr 5, 2025
Grew 27% QoQ from 11 to 14 employees.
Aglaris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aglaris's valuation, stock price, and market status.
Is Aglaris a public or private company?
Aglaris is a private company.
What is the current stock price of Aglaris?
Aglaris is a private company with no public stock price. No recent secondary market data is available.
How much is Aglaris worth (valuation)?
Valuation information for Aglaris is not publicly available.
Can I buy Aglaris stock?
Aglaris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aglaris's last funding round?
Aglaris's most recent funding round was Grant on April 1, 2019.
Who are the main investors in Aglaris?
Key investors in Aglaris include CRB Bio II.
Will Aglaris IPO soon?
No public IPO plans have been announced for Aglaris.
How can I track Aglaris secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aglaris's secondary market activity and sign up for updates.